(Q39138641)

9 September 2017

title

Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503

8 October 2022

main subject

arterial hypertension

0 references

essential hypertension

1 reference

5

P Corvol

1 reference

9 September 2017

J. Menard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503

8 October 2022

X. Bertagna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503

8 October 2022

P. T. N'Guyen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503

8 October 2022

P. Degoulet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14503

8 October 2022

language of work or name

English

0 references

publication date

1 May 1976

1 reference

9 September 2017

31 May 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14503

full work available at URL

8 October 2022

https://api.elsevier.com/content/article/PII:0002934376909098?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

https://api.elsevier.com/content/article/PII:0002934376909098?httpAccept=text/plain

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

American Journal of Medicine

15 October 2022

published in

1 reference

9 September 2017

volume

60

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

886-890

1 reference

HYPOTENSIVE ACTION OF PRONETHALOL.

9 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Treatment of Hypertension with Propranolol

15 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Antihypertensive therapy with alprenolol, a beta-adrenergic receptor antagonist

15 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

A comparison of timolol and propranolol in essential hypertension

15 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness

15 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Hypotensive action of propranolol

15 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

15 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Clinical pharmacology of propranolol

15 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.

15 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man

15 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties

15 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A

15 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Cardiac and pulmonary effects of acebutolol

15 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Clinical conference: Essential hypertension: new concepts about mechanisms

15 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

15 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

15 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Hypotensive and renin-suppressing activities of propranolol in hypertensive patients

15 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension

15 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

Beta-blockers and plasma renin activity in hypertension.

15 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension

15 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(76)90909-8

15 October 2022

Identifiers

1 reference

9 September 2017

1 reference